Abstract-We present the status and initial images of a positron tomograph for prostate imaging that centers a patient between a pair of external curved detector banks (ellipse: 45 cm minor, 70 cm major axis). The distance between detector banks adjusts to allow patient access and to position the detectors as closely as possible for maximum sensitivity with patients of various sizes. Each bank is composed of two axial rows of 20 CTI PET Systems HR+ block detectors for a total of 80 detectors in the camera. Compared to an ECAT HR PET system operating in 3D mode, our camera uses about one-quarter the number of detectors and has approximately the same sensitivity for a central point source, because our detectors are close to the patient. The individual detectors are angled in the plane to point towards the prostate to reduce resolution degradation in that region. The detectors are read out by modified CTI data acquisition electronics. We have completed construction of the gantry and electronics, have developed detector calibration and data acquisition software, and are taking coincidence data. We demonstrate that we can clearly visualize a "prostate" in a simple phantom. Reconstructed images of two phantoms are shown.
I. INTRODUCTION
W E present the development of a positron emission tomograph optimized to image the prostate. This instrument images radiopharmaceuticals that specifically localize in the prostate to confirm the presence, absence or progression of disease. It has approximately four times fewer detectors than an ECAT HR or HR+ PET scanner, which will reduce the cost and potentially increase clinical availability.
Prostate cancer has a prevalence and diagnostic rate similar to breast cancer, with 230 000 new cases diagnosed in the United States each year and one man in 6 diagnosed during his lifetime [1] . Prostate cancer suspicion is typically based on an elevated prostate-specific antigen (PSA) level or a suspicious mass found during a digital rectal exam. Treatment decision is based mainly on biopsy confirmation of prostate cancer [1] . Typical treatment options include prostatectomy, external beam irradiation, brachytherapy (interstitial implantation of radioactive seeds), androgen ablation (hormonal) therapy, or "watchful waiting" [2] . Major problems with prostate cancer therapy are the questions of where to biopsy, when to treat, or whether to treat at all. This is particularly problematic in the case of an increased PSA level with non-diagnostic repeated biopsies or after a prostatectomy [3] , [4] . A new imaging technology for sensitive detection of prostate cancer is needed to confirm initial diagnosis, guide biopsy and help guide treatment decisions. In addition, a new method is needed to assess response shortly after a treatment intervention. In order to help meet these needs, we have built a PET camera optimized to image the prostate. Functional PET imaging will help detect malignant tumors in the prostate and/or prostate bed as a follow-up for an elevated PSA level, as well as possibly help determine tumor "aggressiveness" based on metabolic uptake levels. Although not optimized to detect distant metastatic disease, this PET camera may also image local spread near the prostate bed to help guide treatment decisions such as whether a narrow or wide irradiation treatment field is needed. However, metastatic disease detection will be limited by the axial extent of the camera.
Although there has been worldwide interest in developing and building specialized cameras for breast and small animal imaging, only a few groups have recently developed instrumentation optimized to image prostate cancer. Existing work includes instrumentation development for prostate cancer imaging in the areas of PET [5] - [9] , Compton probes [10] , [11] , SPECT/CT and MRI/MRSI [12] .
Promising PET radiopharmaceuticals have recently demonstrated sensitive detection of prostate cancer, inspiring a new interest in using PET for prostate cancer imaging. Consistent with the evidence of increased pool size of choline in prostate cancer [13] , [14] , Hara and co-workers find that: [ C]choline clears the blood faster than FDG; its uptake in prostate tumors is significantly higher than in normal and surrounding tissues [15] , [16] , providing excellent tumor/normal contrast; and bladder accumulation is minimal if the correct time course is chosen [17] , which is a major advantage over FDG. Therefore, [ C] choline is an attractive PET tracer for imaging primary and metastatic tumors of the prostate and potentially for other regions of the body [18] - [22] . Other C radiopharmaceuticals also show promise for prostate cancer PET imaging, including [ C]acetate [23] - [25] and [ C]methionine [26] - [29] . F imaging has the advantage of a longer half-life, which increases clinical utility because an on-site cyclotron facility would not be necessary (as it would for C imaging). Although many groups have shown that PET imaging with [ F] fluorodeoxyglucose (FDG) is not a good technique for prostate cancer diagnosis [30] , [31] , there are several other F radiopharmaceuticals currently under investigation including [ F]fluorocholine (FCH) [32] , [33] . PET images using [ F]fluorocholine demonstrate high standardized uptake values (e.g., SUV of 8), indicating that FCH is well localized in the prostate cancer and can be imaged with good resolution if short scan times ( five minutes) are used to avoid bladder background [32] .
II. CAMERA DESIGN

A. Overview
These new prostate cancer tracers motivated us to build an efficient, sensitive and relatively inexpensive PET camera optimized to image the prostate. Coincidence imaging of positron emitters is achieved using a pair of external curved detector banks, one placed above and one below the patient. Fig. 1 shows the transaxial and sagittal views of the camera. The bottom bank is fixed below the patient bed, and the top bank moves upward for patient access and downward for maximum sensitivity. Each bank consists of two axial rows of 20 CTI ECAT HR+ block detectors for a total of 80 detectors per camera. The two banks form an incomplete elliptical ring of detectors with a minor axis of 45 cm and major axis of 70 cm. Our prostate camera has about one-fourth the number of detectors as an EXACT HR or HR because: (a) the patient is not fully encircled in 2D, (b) an elliptical shape is used instead of a circular one, and (c) the axial coverage is only 8 cm. The reduced number of detectors and electronics will significantly lower the cost of the camera. The camera has a reduced axial extent and thus better shielding than a conventional whole body PET scanner, which reduces the number of scatter and random events. The average distance to our detectors is about one-half that of a conventional PET system. Hence, we achieve lower backgrounds and improved detection efficiency in the central imaging volume at a lower cost.
Individual detector modules are angled to point towards the camera center near the prostate location in order to reduce penetration effects (in the detector) for annihilation photons originating in the prostate. This geometry increases resolution selectively in the region of the prostate and is an unique feature for a non-circular camera geometry. Annihilation photons from other parts of the field of view (FOV) will suffer increased penetration effects, but these regions are less important. Both detector banks can be tilted to image the prostate while minimizing attenuation (i.e., above the buttocks and below the stomach, see Fig. 1(b) ), but the gantry allows zero tilt for thin patients. A patient of average size is not fully encircled in 2D, which results in irregular and incomplete sampling due to the side gaps. Despite this incomplete sampling, Monte Carlo simulations demonstrate that we are able to reconstruct nearly artifact free images in the region of interest by using an iterative reconstruction algorithm [5] .
The camera design also includes shielding [5] , as shown in Fig. 1(b) . Inter-module septa extend 5 cm beyond the scintillator crystals to reduce background events from random coincidences and from photons that Compton scatter in the patient [7] . However, we have operated in a septa-less 3D mode for the data presented here. Lead shields are used on the ends to reduce activity from outside the field of view.
B. Electronics
Our camera uses modified commercial components in a novel geometry. We use 80 CTI ECAT HR+ block detectors that are three attenuation lengths thick for good detection efficiency with narrow detector elements (i.e., 8 8 arrays of 4.4 4.1 30 mm BGO crystals) to achieve good spatial resolution. We use modified front end, coincidence, and readout electronics developed by CTI for the HRRT brain imaging PET camera, as shown in Fig. 2 . Since we are creating a non-standard camera with HR+ and HRRT components, a custom conversion board reroutes PMT signals to electronics channel inputs. Events are detected and assigned an arrival time, the crystal of interaction is identified, energy qualification is performed, and a digital word is formed using 28 CTI HRRT Analog Subsection boards. The output signals from the Analog Subsection boards are then multiplexed by six custom Detector Head Interface (DHI) boards, which are based on the CTI HRRT DHI design but each services a maximum of 15 (rather than 117) detector modules. We use six DHI boards to allow coincidences between detector modules within the same bank and plane. A CTI Coincidence Processor identifies singles events in the different DHI boards that are in coincidence, and the output is sent to a Pentium-based computer system for reconstruction and display. Fig. 3(b) shows a photograph of the camera with the lead shielding on one side removed and a single row of detector modules visible. Each detector module points toward the center of the camera, as discussed in Section II.A. The upper bank is mounted onto an aluminum back-plate whose vertical motion is controlled using a hand-crank, allowing upward movement for patient access and downward motion to maximize sensitivity. A second hand-crank is used to adjust the overall tilt of both upper and lower banks. The readout electronics are mounted on the right housing [within the Unistrut frame visible on the right in Fig. 3(b) ]. The six DHI boards are mounted horizontally to the housing that holds their corresponding Analog Subsection boards. The Coincidence Processor board is mounted onto the cabinet door for compactness. The V and high voltage power supplies are mounted on the left housing. Fig. 3(c) shows the completed camera.
C. Gantry
D. Reconstruction Algorithm
We have developed an iterative penalized maximum likelihood reconstruction algorithm for the prostate camera. The reconstruction software is designed to be very flexible in modeling arbitrary scanner geometry [9] . Forward and back projections at each iteration are calculated using the exact position and orientation of each detector block without any rebinning. The position and orientation of each detector block are taken from the mechanical design specifications, which have been confirmed by measurement of the completed system. Each detector module has an aluminum guide [ Fig. 3(a) ] that slides along a groove in the arc plate and is stopped (and secured against the plate) using a mortise and tenon, thus the detector position with respect to the arc has an uncertainty of mm per coordinate. The relative arc-to-arc alignment (i.e., the position of one detector bank relative to the other) has an uncertainty of less than mm for a relative linear shift and less than 1 for an angular shift.
The crystal penetration effect is modeled using a geometric calculation technique similar to that presented in [34] for a positron emission mammography scanner. The attenuation correction factors are calculated based on the measured phantom geometry and an uniform attenuation coefficient of 0.095/cm. A voxel size of 2 mm 2 mm 2 mm is used. We estimate and subtract the random background using the standard delayed window technique. The reconstruction algorithm [5] is not yet final so we present only initial results. Only events between detector banks were included and a 3D reconstruction was performed. A 300 keV energy threshold and 10 nsec coincidence timing window were used for all measurements.
III. PERFORMANCE
A. Sensitivity and Count Rate
Coincidence event rates were measured by scanning a 1.5 mm diameter 47 Ci Ge point source along the central axis of the patient port in 3 mm steps. Fig. 4 shows the system sensitivity as a function of axial position. The peak absolute sensitivity is 946 cps/ Ci (2.6%) in 3D mode. This is equivalent to the peak absolute sensitivity of the EXACT HR in 3D mode and approximately 8 times higher than the EXACT HR in 2D mode, even though our camera has one-quarter as many detectors. The sensitivity in Fig. 4 has a slight kink at axial positions 30 and 70 mm, corresponding to the center of the detector modules for each axial row, due to a small (1 mm) axial gap between the detector modules.
The count rate as a function of activity density was measured using a 19 cm inner diameter by 20 cm long cylindrical phantom filled with C and centered in the camera. Data were collected in 3D mode for 10 seconds every 3 minutes. Fig. 5(a)   Fig. 4 . System sensitivity as a function of axial position, using a 47 Ci Ge point source. Peak absolute sensitivity in the center of the field of view is 946 cps/Ci (2.6%) in 3D mode, which is the same as an EXACT HR in 3D mode but with one-quarter as many detector modules. Data was collected using a 300 keV energy threshold. shows the count rate as a function of activity density for total, prompt, random and true scatter coincident events. The maximum total count rate was 528 kHz at an 1.5 Ci/ml activity density. Fig. 5(b) shows the count rate at only the lower activity density to show the standard clinical range in greater detail. The trues scatter events cross the randoms at 0.41 Ci/ml.
B. Reconstructed Images
Rectangular planar phantoms are used for normalization. Coincident data are acquired with a 69 cm 10 cm 1 cm planar phantom centered between the detector banks [i.e., placed horizontally in Fig. 3(b) ], in order to correct for the efficiency of the lines of response between detector banks. Coincident data are acquired separately with a 27 cm 10 cm 1 cm planar phantom placed perpendicular to the 69 cm phantom [i.e., placed vertically in Fig. 3(b) ], in order to correct for coincident events that occur within the same detector bank. Rectangular phantom data are taken with the same gap distance as the (patient or phantom) data to be reconstructed. However, we will investigate a normalization method that uses only normalization data corresponding to a standard gap distance. For the reconstructed images shown here, only events between detector banks are included. The 69 cm 10 cm 1 cm planar phantom was filled with uniform F at an initial activity of 308 Ci, and coincident data acquired for three hours. Fig. 6(a) shows a 37-line source phantom. In the transverse plane, single line sources are placed 2, 4, 6, and 8 cm from the central line. Clusters of four line sources are placed radially at 4 and 8 cm from the central line, and the line sources in each cluster are spaced 8, 6, 5, and 4 mm apart. Fig. 6(b) shows the reconstructed image of this 37-line phantom when filled with F at an initial activity of 0.8 mCi and imaged for two hours. Only minor blurring is seen for line sources placed further from the center, demonstrating good resolution in the 16 cm diameter central region where the prostate will be positioned. We are able to resolve line sources that are separated by 5 mm when placed at a diameter of 8 cm and 16 cm.
Spatial resolution was measured by imaging a 1-inch 20-gauge needle filled with 26 Ci F solution at three positions in the field of view. Relative to the camera center, the needle was imaged at transverse positions (0, 1 cm), (0, 10 cm) and (10 cm, 0) in accordance with the NEMA standard. Fig. 7(a) shows the combined reconstructed images. The transverse spatial resolution at 1 cm is 4 mm full width at half maximum (FWHM). At 10 cm, the average transverse radial resolution is 5.5 mm FWHM and average transverse tangential resolution is 4 mm FWHM. Fig. 7(b) shows the profile in the y direction for the needle positioned at (0, 1 cm) and (0, 10 cm); only minor blurring is seen for the point source placed 10 cm from the center. Ideally a filtered back projection reconstruction would be used when measuring the spatial resolution, as specified by the NEMA standard, but this is difficult for our geometry. Instead, we added an uniform background to the point source data set and reconstructed with our standard iterative algorithm. However, an insufficient amount of background was added, so the non-negativity constraint was still active. Fig. 8(a) shows a concentric-cylinder phantom, which is centered between the detector banks. The outer compartment has a diameter of 19 cm, the inner has a diameter of 4 cm, and both compartments have a length of 20 cm. The inner and outer compartments of the phantom were partially filled with F at an uniform initial activity of 28 Ci (in 0.26 liters) and 150 Ci (in 4.1 liters), respectively. Thus the activity density in the inner compartment (0.11 Ci/ml) was three times higher than in the outer compartment (0.036 Ci/ml). For comparison, the expected activity concentration for humans is about 0.13 Ci/ml. Fig. 8(b) shows the reconstructed image of this phantom when imaged for one hour, as well as the horizontal profile through the center. We can clearly reconstruct the simple prostate phantom with only minor artifacts in the uniform "body" distribution. Artifacts are due to incomplete sampling from the detector bank gaps, and these artifacts will reduce when we include events that are coincident within the same detector bank.
IV. DISCUSSION
PET radiopharmaceuticals have recently demonstrated promising results in the sensitive detection of prostate cancer. Initially we plan to image using [ C]choline. In the future, this camera can be used to evaluate new prostate cancer radiopharmaceuticals. The high sensitivity of this new design can achieve clinical imaging wherein short duration scans are needed to avoid bladder background accumulation of tracers.
Accurate patient positioning is critical due to the limited (8 cm) axial extent of the camera. The prostate is visible in ultrasound images acquired with an external or transrectal transducer, and we plan to use ultrasound to position the patient bed. Finally, it is difficult to identify features other than the prostate and the bladder in the PET images. Local anatomic information is highly desirable to determine the location of the disease within the prostate, as well as to determine whether the disease has spread to the prostate bed. This information could be obtained with dual-modality imaging. X-ray CT provides excellent images of the abdomen, but the cost is relatively high. Ultrasound imaging with a transrectal probe provides high resolution anatomical detail in the region of the prostate and the cost of an ultrasound unit is significantly less than that of a CT unit. We are exploring dual-modality prostate imaging with PET and ultrasound, in order to guide subsequent diagnosis and treatment procedures.
V. CONCLUSION
Promising new PET tracers for prostate cancer, such as [ C]choline and [ C]acetate, have motivated us to build a PET camera optimized for prostate imaging. Reconstructed images of extended and line source phantoms demonstrate the feasibility of imaging prostate tumors with good spatial resolution and image contrast at low cost relative to commercial whole body PET scanners. The same sensitivity as ECAT HR in 3D mode is achieved using only one-quarter the number of detector modules and an axial length of 8 cm. Before the camera is ready for patient studies, we plan to finalize the reconstruction algorithm and the automated calibration software to improve image quality.
